GENOMIC HEALTH INC (GHDX) has 434 open-market insider trades by 35 insiders since 2006. The most active filer is Julian Baker, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| BAKER Bros. Advisors L.P. via Julian Baker | Dir10% Owner | — | 28 | $319.6M | 2019-04-12 |
| Felix Baker | Dir10% Owner | — | 47 | $131.7M | 2019-04-12 |
| 667, L.P. | Dir10% Owner | — | 19 | $130.8M | 2019-10-01 |
| 14159, L.P. | Dir10% Owner | — | 13 | $128.8M | 2019-06-14 |
| Baker Brothers Life Sciences LP | Dir10% Owner | — | 14 | $128.2M | 2019-03-14 |
| Julian Baker | Dir10% Owner | — | 50 | $108.9M | 2019-08-29 |
| Baker Bros. Advisors (GP) LLC via Felix Baker | Dir10% Owner | — | 6 | $86.5M | 2019-03-19 |
| Brothers Life Sciences Capital (gp) Llc Baker | Dir10% | — | 13 | $55.8M | 2012-03-05 |
| Baker/Tisch Investments, LP | Dir10% Owner | — | 5 | $46.4M | 2019-03-19 |
| Steven Shak | CSO | — | 42 | $41.1M | 2019-09-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Laura Leber | CCO | Sell | $1.9M | 2019-10-17 |
| James J. Vaughn | CCO | Sell | $305K | 2019-10-08 |
| Kimberly J. Popovits | CEO & President | Sell | $677K | 2019-10-08 |
| G. Bradley Cole | CFO | Sell | $3.1M | 2019-10-07 |
| Steven Shak | CSO | Sell | $1.8M | 2019-09-17 |
| G. Bradley Cole | CFO | Sell | $1.3M | 2019-09-10 |
Companies that share insiders with GHDX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| G. Bradley Cole | CFO | Sell | $6.1M | 2019-09-09 |
| Kimberly J. Popovits | CEO & President | Sell | $1.4M | 2019-09-09 |
| G. Bradley Cole | CFO | Sell | $1.8M | 2019-09-09 |
| James J. Vaughn | CCO | Sell | $311K | 2019-09-09 |
| James J. Vaughn | CCO | Sell | $326K | 2019-09-09 |
| James J. Vaughn | Chief Commercial Officer | Sell | $15K | 2019-09-09 |
| Frederic Pla | COO | Sell | $94K | 2019-08-19 |
| Jason W. Radford | CLO | Sell | $316K | 2019-08-15 |
| Kimberly J. Popovits | CEO & President | Sell | $1.9M | 2019-08-13 |